{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:56:40Z","timestamp":1787007400851,"version":"build-2736575974"},"reference-count":45,"publisher":"Informa UK Limited","issue":"10","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundations of China","doi-asserted-by":"crossref","award":["82073894"],"award-info":[{"award-number":["82073894"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"New Medicine Clinical Research Fund","award":["4246Z512"],"award-info":[{"award-number":["4246Z512"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anti-infective Therapy"],"published-print":{"date-parts":[[2024,10,2]]},"DOI":"10.1080\/14787210.2024.2397663","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T10:07:07Z","timestamp":1726049227000},"page":"867-875","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy and safety of eravacycline (ERV) in treating infections caused by Gram-negative pathogens: a systematic review and meta-analysis"],"prefix":"10.1080","volume":"22","author":[{"given":"Zehua","family":"Chen","sequence":"first","affiliation":[{"name":"Center of Medicine Clinical Research, Department of Pharmacy, Medical Supplies Center, Chinese PLA General Hospital, Beijing, China"},{"name":"Medical School of Chinese PLA, Graduate School of Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijia","family":"Sun","sequence":"additional","affiliation":[{"name":"Medical Supplies Center, Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulong","family":"Chi","sequence":"additional","affiliation":[{"name":"Center of Medicine Clinical Research, Department of Pharmacy, Medical Supplies Center, Chinese PLA General Hospital, Beijing, China"},{"name":"Medical School of Chinese PLA, Graduate School of Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Liang","sequence":"additional","affiliation":[{"name":"Center of Medicine Clinical Research, Department of Pharmacy, Medical Supplies Center, Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Cai","sequence":"additional","affiliation":[{"name":"Center of Medicine Clinical Research, Department of Pharmacy, Medical Supplies Center, Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,9,11]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-023-00791-6"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-018-0048-6"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30605-4"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01288-13"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02206-17"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12010063"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.2217\/fmb-2019-0135"},{"key":"e_1_3_5_9_1","unstructured":"XERAVA (eravacycline) for injection for intravenous use initial U.S. Approval. 2018 Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/211109lbl.pdf"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2014.965253"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-biochem-062917-011942"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.06187-11"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02036-13"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106844"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.935343"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8060866"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2021.02.009"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2385"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-010-9491-z"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(95)00134-4"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01614-13"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2016.4237"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy1029"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1177\/10600280221085551"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-020-00351-0"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa071"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2021.10.020"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00479-22"},{"issue":"12","key":"e_1_3_5_29_1","first-page":"1634","article-title":"Multicenter real-world experience with eravacycline targeted for gram-positive infections","volume":"4","author":"Alosaimy S","year":"2021","unstructured":"Alosaimy S, Molina K, Lena Kang-Birken S, et al. Multicenter real-world experience with eravacycline targeted for gram-positive infections. JACCP J Am Coll Clin Pharm. 2021;4(12):1634\u20131635.","journal-title":"JACCP J Am Coll Clin Pharm"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa439.1454"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxac098"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2023.09.012"},{"key":"e_1_3_5_33_1","unstructured":"European committee on antimicrobial susceptibility testing breakpoint tables for interpretation of MICs and zone diameters version 14.0 valid from 2024-01-01."},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2017.06.022"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00436-16"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00058-07"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa372"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-020-00807-5"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-020-0966-5"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2022.05.020"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11101298"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa386"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.33393\/dti.2023.2622"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkn242"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku561"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01390-22"}],"container-title":["Expert Review of Anti-infective Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14787210.2024.2397663","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T05:07:07Z","timestamp":1732770427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14787210.2024.2397663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,11]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10,2]]}},"alternative-id":["10.1080\/14787210.2024.2397663"],"URL":"https:\/\/doi.org\/10.1080\/14787210.2024.2397663","relation":{},"ISSN":["1478-7210","1744-8336"],"issn-type":[{"value":"1478-7210","type":"print"},{"value":"1744-8336","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-05-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}